Financial Assistance
Newsletter Sign-up
Need Appointment
Contact Us
About Us

Rush University
For Physicians
For Rush Employees
For Students
Bill Payment Center
Rotate

Roumen D. Balabanov, MD

Roumen D. Balabanov, MD
Appointment Request

Or call
(888) 352-RUSH for help arranging an appointment.
Specialty:
  • Neurology
Board Certification:
  • Neurology
Faculty Rank: Associate Professor
Medical or Graduate Education: Medical Academy, Sofia, Bulgaria
Residency: University of Chicago Medical Center - Neurology
Fellowship: University of Chicago Medical Center - Demyelinating Diseases
Clinical Expertise:
  • Autoimmune disorders
  • Central nervous system infections
  • Central nervous system vasculitis
  • Demyelinating diseases
  • Guillain-Barre syndrome
  • Multiple sclerosis
  • Myasthenia gravis
  • Transverse myelitis
Research Interests:
  • Autoimmune and demyelinating diseases of the nervous system
  • immunotherapy
Languages Spoken:
  • Bulgarian
Google Map
  • Rush University Multiple Sclerosis Center
  • 1725 W. Harrison St.
  • Suite 309
  • Chicago, IL  60612
  • Phone: (312) 942-8011
  • Fax: (312) 942-2253
  • View Larger MapDriving Directions

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.

  1. Immunotherapy of neuromyelitis optica.
    Bienia B, Balabanov R
    Autoimmune Dis
    2013
    2013:741490.
  2. Cross-immunoreactivity between bacterial aquaporin-Z and human aquaporin-4: potential relevance to neuromyelitis optica.
    Ren Z, Wang Y, Duan T, Patel J, Liggett T, Loda E, Brahma S, Goswami R, Grouse C, Byrne R, Stefoski D, Javed A, Miller SD, Balabanov R.
    J Immunol. 2012
    2012 Nov 1
    189(9):4602-11. doi: 10.4049/jimmunol.1200486. Epub 2012 Sep 24.
  3. Autologous hematopoietic stem cell transplantation for multiple sclerosis--if confused or hesitant, remember: 'treat with standard immune suppressive drugs and if no inflammation, no response'.
    Burt RK, Balabanov R, Voltarelli J, Barreira A, Burman J.
    Mult Scler. 2012
    2012 Jun
    18(6):772-5. doi: 10.1177/1352458512442993. No abstract available.
  4. Interferon regulatory factor 1 regulation of oligodendrocyte injury and inflammatory demyelination.
    Loda E, Balabanov R.
    Rev Neurosci. 2012
    2012 Jan 26
    23(2):145-52. doi: 10.1515/revneuro-2011-068. Review.
  5. Molecular mechanisms of oligodendrocyte injury in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Patel J, Balabanov R.
    Int J Mol Sci. 2012
    2012
    13(8):10647-59. doi: 10.3390/ijms130810647. Epub 2012 Aug 23.
  6. Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment in MS.
    Ko MY, Stefoski D, Balabanov R.
    Neurology. 2011
    2011 Sep 6
    77(10):1020; author reply 1020. doi: 10.1212/WNL.0b013e31822946d0. No abstract available.
  7. Overexpression of the dominant-negative form of interferon regulatory factor 1 in oligodendrocytes protects against experimental autoimmune encephalomyelitis.
    Ren Z, Wang Y, Tao D, Liebenson D, Liggett T, Goswami R, Clarke R, Stefoski D, Balabanov R.
    J Neurosci. 2011
    2011 Jun 8
    31(23):8329-41. doi: 10.1523/JNEUROSCI.1028-11.2011.
  8. The CNS microvascular pericyte: pericyte-astrocyte crosstalk in the regulation of tissue survival.
    Bonkowski D, Katyshev V, Balabanov RD, Borisov A, Dore-Duffy P.
    Fluids Barriers CNS. 2011
    2011 Jan 18
    8(1):8. doi: 10.1186/2045-8118-8-8.
  9. IRF-1 signaling in central nervous system glial cells regulates inflammatory demyelination.
    Ren Z, Wang Y, Liebenson D, Liggett T, Goswami R, Stefoski D, Balabanov R.
    J Neuroimmunol. 2011
    2011 Apr
    233(1-2):147-59. doi: 10.1016/j.jneuroim.2011.01.001. Epub 2011 Jan 22.
  10. Methylation patterns of cell-free plasma DNA in relapsing-remitting multiple sclerosis.
    Liggett T, Melnikov A, Tilwalli S, Yi Q, Chen H, Replogle C, Feng X, Reder A, Stefoski D, Balabanov R, Levenson V.
    J Neurol Sci. 2010
    2010 Mar 15
    290(1-2):16-21. doi: 10.1016/j.jns.2009.12.018. Epub 2010 Jan 12.
  11. Central nervous system expression of interferon regulatory factor 1 regulates experimental autoimmune encephalomyelitis.
    Ren Z, Wang Y, Tao D, Liebenson D, Liggett T, Goswami R, Stefoski D, Balabanov R.
    J Neuroimmune Pharmacol. 2010
    2010 Jun
    5(2):260-5. doi: 10.1007/s11481-010-9193-z. Epub 2010 Feb 23.
  12. STAT1/IRF-1 signaling pathway mediates the injurious effect of interferon-gamma on oligodendrocyte progenitor cells.
    Wang Y, Ren Z, Tao D, Tilwalli S, Goswami R, Balabanov R.
    Glia. 2010
    2010 Jan 15
    58(2):195-208. doi: 10.1002/glia.20912.
  13. Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study.
    Burt RK, Loh Y, Cohen B, Stefoski D, Balabanov R, Katsamakis G, Oyama Y, Russell EJ, Stern J, Muraro P, Rose J, Testori A, Bucha J, Jovanovic B, Milanetti F, Storek J, Voltarelli JC, Burns WH.
    Lancet Neurol. 2009
    2009 Mar
    8(3):244-53. doi: 10.1016/S1474-4422(09)70017-1. Epub 2009 Jan 29. Erratum in: Lancet Neurol. 2009 Apr;8(4):309. Stefosky, Dusan [corrected to Stefoski, Dusan].

Find a Doctor | Patient & Visitor Services | Health Information | Clinical Services | Events & Classes | News Room | Clinical Trials | Research at Rush
Nursing at Rush | Work at Rush | Giving to Rush | Directions to Rush | Disclaimer | Privacy Statement
For Physicians | For Rush Employees | For Students | Bill Payment Center | Site Map
© Rush University Medical Center
1653 W. Congress Parkway, Chicago, Illinois 60612